DOZENS of new cancer drugs made available to patients in Europe between 2014 and 2016 were approved on the basis of clinical trials found to be at "high risk of bias", researchers have warned. They said the treatment effects may have been exaggerated ...
from Google Alert - health https://ift.tt/31zrOjj
via IFTTT
0 comments:
Post a Comment